Actively Recruiting
The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Led by Cedars-Sinai Medical Center · Updated on 2025-08-20
1000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria of Takotsubo Registry protocol. Subjects will also be invited to provide a blood sample utilizing a Mitra kit sent to their homes. Researchers from the Barbra Streisand Women's Heart Center will analyze Registry data to identify Takotsubo phenotypes, improve diagnostic capabilities, better predict recurrence rates, and develop targeted Takotsubo treatments.
CONDITIONS
Official Title
The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have received a diagnosis of Takotsubo from their physician and consent to enroll
- Submit full medical records needed for Takotsubo adjudication
You will not qualify if you...
- Younger than 18 years
- Unable to provide informed consent
- Unable to provide the necessary documentation needed for screening purposes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cedars Sinai Medical Center
Los Angeles, California, United States, 90005
Actively Recruiting
Research Team
T
TS Registry
CONTACT
B
BS WHC, MS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here